Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation

Citations Over TimeTop 1% of 2016 papers

Abstract

Emerging evidence indicates that osteoclasts direct osteoblastic bone formation. MicroRNAs (miRNAs) have a crucial role in regulating osteoclast and osteoblast function. However, whether miRNAs mediate osteoclast-directed osteoblastic bone formation is mostly unknown. Here, we show that increased osteoclastic miR-214-3p associates with both elevated serum exosomal miR-214-3p and reduced bone formation in elderly women with fractures and in ovariectomized (OVX) mice. Osteoclast-specific miR-214-3p knock-in mice have elevated serum exosomal miR-214-3p and reduced bone formation that is rescued by osteoclast-targeted antagomir-214-3p treatment. We further demonstrate that osteoclast-derived exosomal miR-214-3p is transferred to osteoblasts to inhibit osteoblast activity in vitro and reduce bone formation in vivo. Moreover, osteoclast-targeted miR-214-3p inhibition promotes bone formation in ageing OVX mice. Collectively, our results suggest that osteoclast-derived exosomal miR-214-3p transfers to osteoblasts to inhibit bone formation. Inhibition of miR-214-3p in osteoclasts may be a strategy for treating skeletal disorders involving a reduction in bone formation.

Related Papers

• → Regulation of osteoclast-mediated bone resorption by microRNA(2022)16 cited
• → Planar catechin increases bone mass by regulating differentiation of osteoclasts in mice(2024)2 cited
• → Co-culture of MG63 osteoblast-like cells and human osteoclast precursors: In vitro models of osteoblast–osteoclast communication focused on the osteoclastogenic response(2012)1 cited
• → Endotoxin inhibition of macrophage-mediated bone resorption(1981)17 cited
• Effect of GM-CSF and its inducing osteoclast on the proliferation of osteoblast(2007)